Advanced Precancerous Lesions
Advanced Precancerous Lesions - Related Videos
12:43
Advanced Confocal Microscopy Techniques to Study Protein-protein Interactions and Kinetics at DNA Lesions
0 Views •
Cited by 8 •
2017
Laser microirradiation is a useful tool for studies of DNA repair in living cells. A methodological approach for the use of UVA lasers to induce various DNA lesions is shown. We have optimized a method for local microirradiation that maintains the normal cell cycle; thus, irradiated cells proceed through mitosis.
09:22
Sectioning Mammary Gland Whole Mounts for Lesion Identification
0 Views •
Cited by 13 •
2017
We developed a method to successfully remove, process, section, and stain, for histopathological evaluation, mammary tissue that had originally been fixed on slides as whole mounts. This method may promote the collection and evaluation of mammary gland whole mounts in reproductive and developmental test guideline studies.
06:43
Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
0 Views •
Cited by 51 •
2013
We describe procedures to quantify and characterize atherosclerotic lesions in mouse models using precision sectioning of the aortic sinus and ascending aorta combined with histochemical and immunohistochemical analysis.
09:06
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
0 Views •
Cited by 1 •
2019
We propose a standardized protocol to characterize the cellular composition of late-stage murine atherosclerotic lesions including systematic methods of animal dissection, tissue embedding, sectioning, staining, and analysis of brachiocephalic arteries from atheroprone smooth muscle cell lineage tracing mice.
10:09
Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
0 Views •
Cited by 121 •
2012
A protocol for performing unilateral 6-OHDA lesions of the medial forebrain bundle in mice is described. This method has a low mortality rate (13.3 %) with 89% of the surviving animals showing >95% loss of striatal dopamine and 90.63±-4.02 % ipsiversive rotational bias towards the side of the lesion.
FAQs
Progression reflects the accumulation of genetic and epigenetic alterations that disrupt normal growth control and cellular maturation. These changes can give certain cell populations a selective advantage, allowing them to expand as clones within the tissue. Studying this sequence helps explain how abnormal tissue can become increasingly dysplastic while remaining distinct from established invasive cancer.
Histopathology is central because it reveals high-grade dysplasia and related abnormalities in tissue architecture and cell maturation. The examination helps characterize how substantially the tissue has diverged from normal organization and supports clinical risk assessment. In some organs, imaging or endoscopy can add visual evidence, but tissue evaluation provides an important basis for classification.
The tissue boundary marks a critical distinction between advanced precancerous change and invasive malignancy. A lesion may show substantial dysplasia, abnormal growth, and clonal expansion yet remain on the noninvasive side of that boundary. Determining this status affects interpretation, because the clinical objective is to identify and manage high-risk change before invasion develops.
Detection may begin with imaging or endoscopy in organs where these methods can reveal suspicious abnormalities. Clinicians can then use targeted biopsy to obtain tissue for histopathologic assessment, while the findings support risk stratification. This workflow connects visual or procedural detection with microscopic evaluation, helping distinguish clinically important lesions from changes requiring different management.
Risk stratification organizes lesions according to their apparent likelihood of progressing toward invasion, using findings such as the degree of dysplasia and related histopathologic changes. The resulting assessment can support decisions about surveillance, targeted biopsy, removal, or local treatment. It therefore links diagnostic information with a preventive clinical strategy rather than waiting for invasive disease.
These approaches are used to manage lesions identified as clinically important before they cross into invasive cancer. Surveillance can follow a lesion over time, whereas removal or local treatment addresses the abnormal tissue directly. The choice depends on the lesion’s assessed risk and clinical findings, with the shared goal of preventing progression and improving early intervention.
They provide a model for examining cancer development before invasion, including the effects of genetic and epigenetic change, impaired maturation, and clonal expansion. This makes them useful for evaluating prevention strategies and investigating biomarkers associated with progression. In medicine, such research may improve the ability to identify lesions that warrant closer assessment or intervention.